These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1429 related items for PubMed ID: 9331128

  • 61. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
    Choy H, Akerley W, Safran H, Graziano S, Chung C.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137
    [Abstract] [Full Text] [Related]

  • 62. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie.
    du Bois A, Lück HJ, Meier W, Möbus V, Costa S, Richter B, Bauknecht T, Warm M, Schroeder W, Olbricht S, Nitz U, Jackisch C.
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296
    [Abstract] [Full Text] [Related]

  • 63. A phase I trial with fixed-dose carboplatin and escalating doses of paclitaxel in advanced ovarian cancer.
    Bolis G, Scarfone G, Villa A, Acerboni S, Siliprandi V, Guarnerio P.
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-23-S2-25. PubMed ID: 9045331
    [Abstract] [Full Text] [Related]

  • 64. Phase I study of biweekly paclitaxel and carboplatin for frail patients with advanced non-small cell lung cancer.
    Yanagitani N, Tsuchiya S, Kaira K, Sunaga N, Tsuchiya Y, Sato K, Watanabe S, Nomura S, Sakai S, Saito R, Mori M.
    Am J Clin Oncol; 2007 Oct; 30(5):487-91. PubMed ID: 17921708
    [Abstract] [Full Text] [Related]

  • 65. Paclitaxel and carboplatin in head and neck cancer.
    Dunphy F, Boyd J, Dunleavy T.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-25-S19-27. PubMed ID: 9427261
    [Abstract] [Full Text] [Related]

  • 66. A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial.
    Ichiki M, Kawasaki M, Takayama K, Ninomiya K, Kuba M, Iwami F, Miyazaki N, Oishi K, Takeo S, Aizawa H, Nakanishi Y.
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):368-73. PubMed ID: 16395589
    [Abstract] [Full Text] [Related]

  • 67. Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
    Sørensen JB, Wedervang K, Dombernowsky P.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-18-S12-20. PubMed ID: 9331114
    [Abstract] [Full Text] [Related]

  • 68. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 69. A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer.
    Ford C, Spitzer G, Reilly W, Adkins D.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-81-S17-86. PubMed ID: 9374101
    [Abstract] [Full Text] [Related]

  • 70. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [Abstract] [Full Text] [Related]

  • 71. Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.
    Okamoto I, Moriyama E, Fujii S, Kishi H, Nomura M, Goto E, Kiyofuji C, Imamura F, Mori T, Matsumoto M.
    Jpn J Clin Oncol; 2005 Apr; 35(4):188-94. PubMed ID: 15845567
    [Abstract] [Full Text] [Related]

  • 72. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
    Fountzilas G, Athanassiadis A, Samantas E, Skarlos D, Kalogera-Fountzila A, Nikolaou A, Bacoyiannis H, Stathopoulos G, Kosmidis P, Daniilidis J.
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-65-S2-67. PubMed ID: 9045340
    [Abstract] [Full Text] [Related]

  • 73. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA, Ilson DH, Kelsen DP.
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [Abstract] [Full Text] [Related]

  • 74. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
    Vogt HG, Martin T, Kolotas C, Schneider L, Strassmann G, Zamboglou N.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
    [Abstract] [Full Text] [Related]

  • 75. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study.
    Bunn PA, Kelly KL.
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):54-8; discussion 59-60. PubMed ID: 7481862
    [Abstract] [Full Text] [Related]

  • 76. Paclitaxel, ifosfamide, and carboplatin for the treatment of stages IIIB and IV non-small cell lung cancer: preliminary results.
    Zaniboni A, Meriggi F, Rizzi A, Alghisi A, Pascarella A, Bozzola G, Mutti S, Marini G.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-70-S12-72. PubMed ID: 9331126
    [Abstract] [Full Text] [Related]

  • 77. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
    Choy H, Yee L, Cole BF.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
    [Abstract] [Full Text] [Related]

  • 78. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
    Bonomi P, Faber LP, Recine D, Lincoln S.
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927
    [Abstract] [Full Text] [Related]

  • 79. Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer.
    Nakadate M, Yamazaki K, Konishi J, Kinoshita I, Sukoh N, Harada M, Akie K, Ogura S, Ishida T, Munakata M, Dosaka-Akita H, Isobe H, Nishimura M.
    Anticancer Res; 2006 Aug; 26(5B):3767-72. PubMed ID: 17094399
    [Abstract] [Full Text] [Related]

  • 80. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin.
    Rowinsky EK, Jiroutek M, Bonomi P, Johnson D, Baker SD.
    Clin Cancer Res; 1999 Apr; 5(4):767-74. PubMed ID: 10213211
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 72.